Trial Profile
A phase IIb study investigating the effect of fenretinide in patients with superficial bladder cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2015
Price :
$35
*
At a glance
- Drugs Fenretinide (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 16 Oct 2015 New trial record